Haemonetics Corp SEC filings HAE
Haemonetics Corp has 1,002 filings in SEC EDGAR's recent list, going back to Mar 7, 2013. Its latest annual report, Form ARS, was filed on Jun 9, 2026 for the period ended Mar 28, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 26, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on April 3.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jun 9, 2026 | — |
| DEF 14A | Proxy statement | Jun 9, 2026 | Mar 28, 2026 |
| DEFA14A | Additional proxy material | Jun 6, 2025 | — |
| DEF 14A | Proxy statement | Jun 6, 2025 | Mar 29, 2025 |
| DEFA14A | Additional proxy material | Jun 7, 2024 | — |
| DEF 14A | Proxy statement | Jun 7, 2024 | Mar 30, 2024 |
| DEFA14A | Additional proxy material | Jun 16, 2023 | — |
| DEF 14A | Proxy statement | Jun 16, 2023 | — |
| DEFA14A | Additional proxy material | Jun 17, 2022 | — |
| DEF 14A | Proxy statement | Jun 17, 2022 | Jun 17, 2022 |
| DEFA14A | Additional proxy material | Jun 17, 2021 | — |
| DEF 14A | Proxy statement | Jun 17, 2021 | Jun 18, 2021 |
| DEFA14A | Additional proxy material | Jun 30, 2020 | — |
| DEFA14A | Additional proxy material | Jun 8, 2020 | — |
| DEF 14A | Proxy statement | Jun 8, 2020 | Jul 21, 2020 |
| DEFA14A | Additional proxy material | Jun 12, 2019 | — |
| DEF 14A | Proxy statement | Jun 12, 2019 | Jun 12, 2019 |
| PRE 14A | Preliminary proxy statement | May 22, 2019 | May 21, 2019 |
| DEFA14A | Additional proxy material | Jul 12, 2018 | — |
| DEFA14A | Additional proxy material | Jun 12, 2018 | — |
| DEF 14A | Proxy statement | Jun 12, 2018 | Jul 26, 2018 |
| PRE 14A | Preliminary proxy statement | May 24, 2018 | Jul 26, 2018 |
| DEF 14A | Proxy statement | Jun 12, 2017 | Apr 1, 2017 |
| DEF 14A | Proxy statement | Jun 10, 2016 | Apr 2, 2016 |
| DEFA14A | Additional proxy material | Jun 12, 2015 | — |
| DEF 14A | Proxy statement | Jun 11, 2015 | Mar 28, 2015 |
| DEF 14A | Proxy statement | Jun 13, 2014 | Mar 29, 2014 |
| DEF 14A | Proxy statement | Jun 17, 2013 | Mar 30, 2013 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- HAE (NYSE)
- Fiscal year ends
- April 3
- Incorporated in
- MA
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 313143
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.